A significant expansion in access to treatment helped slash the number of AIDS-related deaths in 2010, bringing the number of people living with HIV to a record 34 million, the United Nations said Monday.
Nov 21, 2011
0
0
(HealthDay)—A common drug used to treat nail fungus may hold promise against HIV, the virus that causes AIDS, according to a new study.
Sep 24, 2013
1
0
New research findings recommend further measures should be put in place to make the best use of two new HIV prevention options.
Dec 9, 2014
0
0
An international team led by Professor Jerome Estaquier from Universite Laval's Faculty of Medicine and the CHU de Quebec-Universite Laval Research Center may have discovered where in the body HIV takes refuge during antiretroviral ...
Dec 2, 2019
0
1
The COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevention services, and directly, by threatening individual health. An effective response to these ...
Apr 8, 2021
0
6
Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in ...
Dec 6, 2011
0
0
Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now ...
Mar 18, 2015
0
53
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...
Dec 17, 2019
0
54
Viral suppression of HIV by antiretroviral medications helps slow transmission of the disease and keep individuals living with it healthy, at times making viral loads so low they are undetectable even on blood tests. Sixty-five ...
Feb 9, 2023
0
3
Researchers have found that using a combination of sofosbuvir and a new drug agent known as daclastasvir is highly successful in treating co-infected hepatitis C (HCV) and HIV patients.
Jul 22, 2015
0
36
